ABSTRACT

Robson, through his landmark articles published in 1963 and 1969, very emphatically demonstrated improved survival in renal cell carcinoma after radical nephrectomy.1,2 Since then radical nephrectomy has been the gold standard treatment for renal cell carcinoma. In the following years, nephron-sparing surgery has emerged as a logical treatment in cases of absolute or imperative indications covering clinical situations such as renal cell carcinoma in solitary kidney, bilateral tumors, and von Hippel-Lindau disease, etc. In these situations nephronsparing surgery would forestall the morbidity of an anephric state and dependence on dialysis or renal transplantation for survival.